Clinical research security · Reviewed September 12, 2026
Clinical Research Cybersecurity Checklist: 12 Controls for Research Sites and CROs
Clinical research environments combine sponsor systems, electronic data capture, eSource, eConsent, email, local workstations, cloud services, laboratory interfaces and sensitive participant information. Security has to protect both confidentiality and the integrity of research records without disrupting study operations.
Security responsibilities are shared
A research site may use systems owned by sponsors, CROs, laboratories, eClinical vendors and the site’s own organization. Start by documenting who owns each platform, who provisions access, who reviews logs, who handles incidents and who can change security settings. Do not assume the site controls every system it uses.
12 controls research organizations should verify
Know every study system
Maintain an inventory of EDC, eSource, eConsent, CTMS, email, file-sharing, laboratory, imaging and other systems used to create, modify, maintain, archive, retrieve or transmit study information.
Limit access to authorized users
Use individual accounts, role-based permissions and documented approvals. Keep a record of who has access to each system and when privileges change.
Strengthen authentication
Use MFA where systems support it, especially for remote access, administrative access and cloud services. Document sponsor/vendor limitations and alternative safeguards.
Protect data integrity
Understand which systems generate audit trails, who can access them and how changes to regulated electronic records can be reconstructed.
Manage research workstations
Maintain visibility into supported devices, endpoint protection, patching, local administrative rights and approved software.
Protect sensitive data
Verify encryption on portable devices and approved storage locations. Avoid unnecessary local copies of participant or study data.
Find technical weaknesses
Scan organization-controlled assets, prioritize remediation and document systems that cannot be tested because they are sponsor- or vendor-managed.
Protect the collaboration layer
Research staff exchange sponsor instructions, documents and access links through email. Use anti-phishing controls and independent verification for sensitive requests.
Plan for outages
Know what the site can restore itself and what depends on sponsors or vendors. Test recovery of local operational data and document downtime procedures.
Map vendor responsibilities
Track eClinical, laboratory, hosting and support providers. Understand contractual security obligations, incident contacts and data-retention responsibilities.
Revoke study access completely
Staff departures may require action across many sponsor portals. Track each external revocation until confirmation instead of closing the task after internal accounts are disabled.
Know who to call
Define when the site contacts the sponsor, CRO, IRB, privacy/security team, vendor or other stakeholders. Exercise the process before an incident occurs.
What FDA guidance says about electronic research systems
FDA’s October 2024 final guidance on electronic systems, electronic records and electronic signatures in clinical investigations discusses restricting system access to authorized users and maintaining records of personnel who are authorized to access electronic systems and their privileges. It also addresses controls intended to support trustworthy and reliable electronic records.
FDA has long emphasized that audit trails for applicable electronic records should support reconstruction of changes, including who made a change and when. Whether a particular system or record is subject to 21 CFR Part 11 depends on its regulatory use and context, so organizations should avoid treating every application as automatically in scope.
FDA final guidance on electronic systems in clinical investigations
Portable research data deserves special attention
NIH’s 2026 Grants Policy Statement advises recipients to protect sensitive and confidential research information and recommends that personally identifiable, sensitive and confidential information not be housed on portable devices when avoidable. When portable devices must be used, NIH advises encryption and appropriate access controls.
For research sites, that means asking practical questions: Can coordinators export participant lists to laptops? Are downloaded files automatically protected? Can data be copied to removable media? What happens when a device is lost, replaced or reassigned?
NIH guidance on protecting sensitive research data
Build an evidence register, not just a policy binder
| Area | Evidence to maintain | Typical owner |
|---|---|---|
| System inventory | System name, study use, owner, sponsor/vendor, data type, support contact | Research operations / IT |
| Access | User list, role, approval, start date, changes and termination confirmation | Study team / operations |
| Endpoints | Managed-device inventory, EDR status, patch status, encryption coverage | IT / MSP |
| Audit trails | System capabilities, review procedure, escalation process | Quality / system owner |
| Vulnerabilities | Scan results, remediation owners, exceptions, closure evidence | IT / security |
| Recovery | Backup scope, downtime plan, restoration test or vendor evidence | IT / operations |
| Vendors | Security review, contract responsibilities, incident contacts | Operations / legal / security |
| Incidents | Response plan, contact tree, exercise notes and corrective actions | Security / leadership |
Common gaps at growing research sites
Too many sponsor portals, no central access register
A coordinator may have access to many sponsor-controlled systems. Build a central list of external accounts and make access review part of study and employment changes.
Study data is downloaded into unmanaged locations
Research workflows can create spreadsheets, PDFs, screenshots and exports outside the primary eClinical platform. Map where those files go and remove unnecessary copies.
The MSP protects laptops but nobody owns research-system governance
Infrastructure support and research governance are different responsibilities. The MSP may manage devices while operations or quality owns sponsor systems, access records and study documentation. Connect the two.
Incident procedures do not include sponsor obligations
A generic IT incident plan may not identify sponsor, CRO, privacy, regulatory or study-specific escalation requirements. Add research-specific contact paths and decision points.
Use a continuous operating model
Map exposure and dependencies
Inventory systems, accounts, devices, vendors and externally visible risks.
Strengthen controls
Address priority identity, endpoint, email, encryption, vulnerability and configuration gaps.
Maintain evidence
Keep access records, configuration evidence, policies, exceptions and remediation records.
Review changes over time
Recheck control coverage as staff, studies, sponsors, vendors and systems change.
Start with a free Clinical Research Cyber Risk Snapshot
NCB Cyber can review publicly observable security conditions associated with your organization’s external footprint before any deeper internal assessment.
Free · No agents · No passwords · No system access
Get My Free Clinical Research Risk Snapshot →Explore Clinical Research Cybersecurity →
Frequently asked questions
Does 21 CFR Part 11 apply to every research application?
No. Applicability depends on whether electronic records or signatures fall within FDA regulatory requirements and the way the system is used. Research organizations should determine scope with their quality, regulatory and legal stakeholders.
Can a clinical research site outsource cybersecurity?
Many technical functions can be managed by an MSP or cybersecurity provider, but sponsor systems, quality responsibilities, access approvals and study-specific obligations still require clear internal ownership.
Does a public Cyber Risk Snapshot assess study systems?
No. The free Snapshot is intentionally non-intrusive and focuses on publicly observable conditions. A deeper review requires agreed scope and authorization.
General cybersecurity information only; not legal, regulatory or GCP advice.